Ann: Regeneus signs MOU with Kyocera Corporation, page-4

Can't argue with you there. If you're looking at 12c then what a good buy at this level. Any new shareholder buying now will probably do ok, thought about buying more but nothing is guaranteed and with considerable losses hard to do.

Adding to the positives:

Directors buying and backing with considerable loans, must have some degree of confidence not just for Progenza in Japan.
Whilst Kyocera's funds are refundable still have to outlay for exclusivity and there is a more specific timeline. You would think that if the product is good then it should be goer.

New Japanese institutional investor, would have knowledge of the Japanese market and processes.

AGC become the largest shareholder and have manufacturing capabilities outside of Japan and looking to participate in Global growth. Could be instrumental in further deals.

Dr John Chiplin and Dr Alan Dunton both successful in big international deals, hopefully can deliver.


If you look at the calibre of those involved you would have to take heart that considerable effort will be made, the timeframe however is another matter.